Hernandez AF, Green JB, Janmohamed S, D'Agostino RB, Sr., Granger CB, Jones NP, Leiter LA, Rosenberg AE, Sigmon KN, Somerville MC, et al: Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
Wear it every day in training and the habit builds fast
Mechanistically, GLP-1R signaling spans Gs-cAMP/PKA, -arrestin-dependent pathways, and additional routes (including Gq contexts), aligning with anti-inflammatory, natriuretic, and antifibrotic effects observed preclinically and clinically
Starting to feel myself again
Accessed April 24, 2024 Share this: Share on X (Opens in new window) X Discover more from Sarah Hormachea Subscribe to get the latest posts sent to your email.